Филтриране по Last updated date SelectСледПредиFrom - To Дата Крайна дата This week This month Last week Last month Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationScientific adviceMedical devicesMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionPRIMEProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filter Резултати (3799) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 May 2021 7 May 2021NewsHumanCOVID-19PharmacovigilanceReferrals EMA starts rolling review of sotrovimab (VIR-7831) for COVID-19 7 May 2021NewsHumanCOVID-19Medicines International regulators and WHO call for wider public access to clinical data 7 May 2021NewsHumanClinical trialsMedicines Confidentiality arrangement between EU and Brazilian regulatory authorities 6 May 2021NewsHumanMedicines Becoming a member of one of EMA’s scientific advisory groups 5 May 2021NewsHumanCorporate EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated 4 May 2021NewsHumanCOVID-19Vaccines EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15 3 May 2021NewsHumanCOVID-19Vaccines EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen 29 April 2021NewsHumanCOVID-19Medicines EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe 26 April 2021NewsHuman AstraZeneca’s COVID-19 vaccine: benefits and risks in context 23 April 2021NewsHumanCOVID-19Vaccines 1 … 62 63 64 65 66 Page 66 of 380 67 68 69 70 … 380
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 3-6 May 2021 7 May 2021NewsHumanCOVID-19PharmacovigilanceReferrals
International regulators and WHO call for wider public access to clinical data 7 May 2021NewsHumanClinical trialsMedicines
Confidentiality arrangement between EU and Brazilian regulatory authorities 6 May 2021NewsHumanMedicines
EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated 4 May 2021NewsHumanCOVID-19Vaccines
EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15 3 May 2021NewsHumanCOVID-19Vaccines
EMA starts evaluating use of Olumiant in hospitalised COVID-19 patients requiring supplemental oxygen 29 April 2021NewsHumanCOVID-19Medicines
EMA and ECDC join forces for enhanced post-marketing monitoring of COVID-19 vaccines in Europe 26 April 2021NewsHuman